Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension
- 1 March 1993
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 71 (7) , 575-581
- https://doi.org/10.1016/0002-9149(93)90514-d
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Effects of Antihypertensive Therapy on Left Ventricular Mass in Elderly PatientsNew England Journal of Medicine, 1990
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextPublished by Elsevier ,1990
- Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasPublished by Elsevier ,1990
- Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertensionThe American Journal of Cardiology, 1987
- Coronary risk prediction in adults (The Framingham Heart Study)The American Journal of Cardiology, 1987
- The Effects of Antihypertensive Drugs on Serum Lipids and LipoproteinsDrugs, 1986
- The Effects of Antihypertensive Drugs on Serum Lipids and Lipoproteins I. Diuretics1Drugs, 1986
- Effects of two antihypertensive agents on lipids, lipoproteins, and apoproteins A and B: Comparison of prazosin and atenololThe American Journal of Medicine, 1986
- Antihypertensive Therapy and LipidsArchives of internal medicine (1960), 1985
- Effect of beta blockers on blood lipid profileAmerican Heart Journal, 1985